Eascra Biotech

Eascra Biotech is focused on developing innovative drug delivery solutions using nanotechnologies. Their proprietary technology platform utilizes Janus Base nanoparticles (JBNps), a novel type of nanoparticle inspired by DNA, to enhance the delivery of mRNA therapeutic agents to difficult-to-penetrate tissues. Eascra Biotech’s products have applications in articular cartilage, central nervous system disorders, solid tumors, and other chronic conditions.